Tohoku J. Exp. Med., 2010, 220(3)

D-4F, an Apolipoprotein A-I Mimetic Peptide, Promotes Cholesterol Efflux from Macrophages via ATP-Binding Cassette Transporter A1

QIONG XIE,1 SHUI-PING ZHAO1 and FENG LI2

1Department of Cardiology, The Second Xiang Ya Hospital of Central South University, Changsha, Hunan, P.R. China
2Department of Cardiothoracic Surgery, The Second Xiang Ya Hospital of Central South University, Changsha, Hunan, P.R. China

Cholesterol efflux is the key step of reverse cholesterol transport and has become a therapeutic target against atherosclerosis. Human apolipoprotein A-I (apoA-I) is the main protein in high-density lipoprotein (HDL) and has 243 amino acids. ApoA-I mimetic peptides have no sequence homology to apoA-I but possess the class-A amphipathic helical motif that presents in apoA-I lipid binding domains. D-4F is one of the apoA-I mimetic peptides and exerts diverse atheroprotective functions similar to apoA-I. However, the exact role of D-4F on lipid metabolism in macrophages is not clear yet. Therefore, we studied the effect of D-4F on cholesterol efflux, cAMP levels and expression of ATP-binding cassette transporter A1 (ABCA1) in RAW264.7 mouse macrophages. Cells were incubated with 1, 10, 50 or 100 μg/ml D-4F for 24 hours, and the cholesterol efflux was assessed. Here, D-4F significantly increased the cholesterol efflux in concentration- and time-dependent manners. Concomitantly, D-4F increased intracellular cAMP levels and the expression levels of ABCA1 mRNA and protein in a dose-dependent manner, consistent with the increase in the cholesterol efflux from macrophages. 8-Br-cAMP (cAMP activator) increased the D-4F-mediated cholesterol efflux by 39%. Moreover, the increases in cholesterol efflux and ABCA1 expression induced by 8-Br-cAMP could be inhibited by the treatment with H89, a protein kinase A (PKA) inhibitor. In conclusion, these results suggest that the synthetic peptide D-4F promotes cholesterol efflux in macrophages through the cAMP-PKA-ABCA1 pathway, which may open new avenues for the treatment of atherosclerosis.

keywords —— apolipoprotein A-I mimetic peptide; cholesterol efflux; macrophage; cyclic AMP; ATP-binding cassette transporter A1

===============================

Tohoku J. Exp. Med., 2010, 220, 223-228

Correspondence: Shui-Ping Zhao, Department of Cardiology, The Second Xiangya Hospital of Central South University, middle Ren-Min road No. 139, Changsha, Hunan 410011, P.R. China.

e-mail: zhaosp@medmail.com.cn, bestxq80@hotmail.com